CRESCENT BIOPHARMA
Live / Applied — Suspended — suspension letter mailed (as of 04 Aug 2026)
What this means for you
Not registered yet, but its 23 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99718436
- Mark type
- Word mark
- Filed
- 23 Mar 2026
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical and biotechnological research and development in the fields of oncology, cancer, and radiology; pharmaceutical and biotechnological research and development
Owner
- Crescent Biopharma, Inc., Waltham, MA, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 04 Aug 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 04 Aug 2026 — LETTER OF SUSPENSION E-MAILED
- 04 Aug 2026 — SUSPENSION LETTER WRITTEN
- 04 Aug 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Aug 2026 — EXAMINER'S AMENDMENT ENTERED
- 04 Aug 2026 — EXAMINERS AMENDMENT E-MAILED
- 04 Aug 2026 — EXAMINERS AMENDMENT -WRITTEN
- 03 Aug 2026 — ASSIGNED TO EXAMINER
- 29 Jul 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 07 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 23 Mar 2026 — NEW APPLICATION ENTERED